Breadcrumb Home News and Resources Share This Share via Twitter Share via Facebook Share via Email Article23 March 2023 A complete list of publications that the SAMU teams have co-authored, reviewed and supported in 2022. HIV-related SAMU Supported Publications1South AfricaAttrition from HIV care among youth initiating ART in youth-only clinics compared with general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysisJIAS2South AfricaHIV Self‑testing Among Previously Diagnosed HIV‑Positive People in Khayelitsha, South Africa: No Evidence of Harm but may Facilitate Re‑engagement in ART CareAIDS Behave3GlobalOutcomes of people living with HIV after hospital discharge: a systematic review and meta-analysisLancet HIV4South AfricaAcceptability of unsupervised peer-based distribution of HIV oral self-testing for the hard-to-reach in rural KwaZulu Natal, South Africa: Results from a demonstration studyPLOS ONE5South AfricaIncrease in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?PLOS ONE6South AfricaAn analysis of the HIV testing cascade of a group of HIV-exposed infants from birth to 18 months in peri-urban Khayelitsha, South AfricaPLOS ONE7Global (editorial)Helping hospitals heal people with HIV and tuberculosisLancet HIV8South AfricaOutcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational studyLancet ID9South AfricaRetention on ART and viral suppression among patients in alternative models of differentiated HIV service delivery in KwaZulu-Natal, South AfricaPLOS Global Health10MalwaiHIV, sexual violence, and termination of pregnancy among adolescent and adult female sex workers in Malawi: A respondent driven sampling studyPLOS ONE11South AfricaRifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosisSouth Afr J HIV Med. Hepatitis, NCDs, Lab, Other1PakistanDAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case seriesOxf Med Case Reports2PakistanDetermining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral based treatment regimens: Evidence from a global data setJVH3GlobalEngineering a sustainable future for point-of-care diagnostics and single-use microfluidic devicesLab on a Chip TB-related SAMU supported publications1South AfricaEarly mortality during rifampicin-resistant TB treatmentIJTLD2IndiaPsychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, IndiaPLOS ONE3South AfricaImplementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South AfricaTrop Med Infect Dis4South AfricaSupporting families with tuberculosis during COVID-19 in Khayelitsha, South AfricaLancet Resp Med5South AfricaWhole genome sequencing has the potential to improve treatment for rifampicin-resistant tuberculosis in high burden settings: a retrospective cohort studyJ Clin Microbiol6Global (editorial)Being heard on all-oral therapy for resistant tuberculosisLancet ID7South AfricaCauses of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South AfricaPublic Health Action8GlobalFeasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods studyJ Clin Tuberc Other Mycobact Dis9South AfricaPrevalence of TB and health-seeking behaviourIJTLD10South AfricaTreatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort studyLancet ID11South AfricaPediatric delamanid treatment for children with rifampicin resistant TBIJTLD12MalawiTB screening, prevention and treatment cascade in a Malawi prisonIJTLD13South AfricaA very sneaky bug: perspectives of front-line clinicians on whole-genome sequencing for drug-resistant TBIJTLD14Global (editorial)Celebrating choice in the care of people living with drug resistant tuberculosisLancet15Global (letter)A test of infection should not be a ‘‘standard’’ for guiding TB preventive therapy in at-risk populationsIJTLD You could also be interested in Tuberculosis Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests Press Release 13 Sep 2023 HIV/AIDS MSF closes HIV/AIDS project after 25 years in Malawi Latest News 3 Aug 2023 Tuberculosis TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries Press Release 14 Jul 2023
Tuberculosis Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests Press Release 13 Sep 2023
Tuberculosis TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries Press Release 14 Jul 2023